Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
FiercePharma
12h
J&J, Legend solidify Carvykti's lead in earlier multiple myeloma with strong survival showing
After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson ...
BioSpace
12h
J&J Posts Positive Phase III Results for Carvykti and Darzalex Faspro in Multiple Myeloma Trials
Johnson & Johnson linked Carvykti to a 45% reduction in risk of death and Darzalex to a 61% improvement in minimal residual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Pete Rose dies at 83
NBA Hall of Famer dies
Helene wreaks havoc
‘Ring of fire’ eclipse in Oct
Blocks songs from artists
Grammy-winning singer dies
Illegal cloning sentencing
NYC tunnel shutdown
Lose 'superhero' trademark
SpaceX Falcon 9 grounded
To lay off 2,900 employees
Settles data breach cases
Nepal floods: Death toll rises
Comer subpoenas Mayorkas
To sue Google, Samsung
Defensive Player of the Year
Mich. nuclear plant to restart
Three PFLP leaders killed
$567M Taiwan defense aid
Line Fire prompts evacuation
'Sing Sing' actor exonerated
Ozzie Virgil Sr. dies at 92
Israel announces operation
Benefit ends today
Red Sox honor radio voice
37 militants killed in Syria
Seeks bribery dismissal
Sells stake in DirecTV
US wins Presidents Cup
Related topics
Bristol-Myers Squibb
2seventy
Feedback